Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesse Godwin

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|December 7, 2016
Flumazenil in benzodiazepine overdoseHoward An, Jesse Godwin
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 30, 2014
Bupropion abuse and overdoseNathan Stall, Jesse Godwin, David Juurlink
CJEM|July 14, 2025
Just the facts: rivastigmine for the management of anticholinergic toxicityJesse Godwin, Stephanie Cheung, Gregory Mah, et al.
CJEM|February 4, 2025
Esmolol for treatment of caffeine overdose: a case reportChristina Botros, Anthony Lau, Jesse Godwin, et al.
Clinical Toxicology (Philadelphia, Pa.)|December 13, 2019
Clinical characteristics and outcomes associated with bupropion overdose: a Canadian perspectiveEmily Stewart, Keerat Grewal, Heather Hudson, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 2, 2018
A 52-year-old man with fentanyl-induced muscle rigidityJane A Buxton, Tim Gauthier, Mai-Lei Woo Kinshella, et al.
Clinical Toxicology (Philadelphia, Pa.)|November 20, 2020
Authors' reply to Comment on Comparison of rates of opioid withdrawal symptoms and reversal of opioid toxicity in patients treated with two naloxone dosing regimensRoy Purssell, Jesse Godwin, Jessica Moe, et al.
Systematic Reviews|June 13, 2019
Naloxone interventions in opioid overdoses: a systematic review protocolLindsay Victoria Shaw, Jessica Moe, Roy Purssell, et al.
CJEM|January 21, 2020
Naloxone dosing in the era of ultra-potent opioid overdoses: a systematic reviewJessica Moe, Jesse Godwin, Roy Purssell, et al.
Clinical Toxicology (Philadelphia, Pa.)|May 14, 2020
Comparison of rates of opioid withdrawal symptoms and reversal of opioid toxicity in patients treated with two naloxone dosing regimens: a retrospective cohort studyRoy Purssell, Jesse Godwin, Jessica Moe, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|December 7, 2016
Flumazenil in benzodiazepine overdoseHoward An, Jesse Godwin
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 30, 2014
Bupropion abuse and overdoseNathan Stall, Jesse Godwin, David Juurlink
CJEM|July 14, 2025
Just the facts: rivastigmine for the management of anticholinergic toxicityJesse Godwin, Stephanie Cheung, Gregory Mah, et al.
CJEM|February 4, 2025
Esmolol for treatment of caffeine overdose: a case reportChristina Botros, Anthony Lau, Jesse Godwin, et al.
Clinical Toxicology (Philadelphia, Pa.)|December 13, 2019
Clinical characteristics and outcomes associated with bupropion overdose: a Canadian perspectiveEmily Stewart, Keerat Grewal, Heather Hudson, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 2, 2018
A 52-year-old man with fentanyl-induced muscle rigidityJane A Buxton, Tim Gauthier, Mai-Lei Woo Kinshella, et al.
Clinical Toxicology (Philadelphia, Pa.)|November 20, 2020
Authors' reply to Comment on Comparison of rates of opioid withdrawal symptoms and reversal of opioid toxicity in patients treated with two naloxone dosing regimensRoy Purssell, Jesse Godwin, Jessica Moe, et al.
Systematic Reviews|June 13, 2019
Naloxone interventions in opioid overdoses: a systematic review protocolLindsay Victoria Shaw, Jessica Moe, Roy Purssell, et al.
CJEM|January 21, 2020
Naloxone dosing in the era of ultra-potent opioid overdoses: a systematic reviewJessica Moe, Jesse Godwin, Roy Purssell, et al.
Clinical Toxicology (Philadelphia, Pa.)|May 14, 2020
Comparison of rates of opioid withdrawal symptoms and reversal of opioid toxicity in patients treated with two naloxone dosing regimens: a retrospective cohort studyRoy Purssell, Jesse Godwin, Jessica Moe, et al.
Pageof 1